Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: Is treatment worthwhile?

British Journal of Cancer

Volumn 84, Issue 12, 2001, Pages 1577-1585

  Jansen, S J T ^a   Kievit, J ^a   Nooij, M A ^a   De Haes, J C J M ^b   Overpelt, I M E ^a   Van Slooten, H ^c   Maartense, E ^d   Stiggelbout, A M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Diaconessen Hospital   (Netherlands)

^d Reinier de Graaf Gasthuis ^*  (Netherlands)

Author keywords

Breast cancer; Chemotherapy; Cognitive dissonance reduction; Preferences; Shared decision making

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PRIORITY JOURNAL;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DATA COLLECTION; DECISION MAKING; DEMOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS;

EID: 0035875522     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1836     Document Type: Article

References (32)

1. Regret in decision making under uncertainty
2. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer
3. Management preferences in stage I non-seminomatous germ cell tumours of the testis: An investigation among patients, controls and oncologists
4. Adjuvant cytotoxic chemotherapy for early breast cancer: Doubts and decisions
5. Polychemotherapy for early breast cancer: An overview of the randomised trials
6. Patients' preferences for therapy in advanced epithelial ovarian cancer: Development, testing, and application of a bedside decision instrument
7. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
8. The effect of individually assessed preference weights on the relationship between holistic utilities and nonpreference-based assessment
9. Test-retest reliabilities of two treatment-preference instruments in measuring utilities
10. Quality of life in stage II breast cancer: An instrument for clinical trials
11. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer
12. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer
13. Investigating patients' preferences for different treatment options
14. Using a tradeoff technique to assess patients' treatment preferences for benign prostatic hyperplasia
15. On the elicitation of preferences for alternative therapies
16. Patient preferences for treatment of metastatic breast cancer: A study of women with early-stage breast cancer
17. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate
18. Effects of framing and level of probability on patients' preferences for cancer chemotherapy
19. Breast cancer patients' attitudes about rationing postlumpectomy radiation therapy: Applicability of trade-off methods to policy-making
20. Breast cancer: The real challenge
21. Adjuvant chemotherapy for breast cancer: Discordance between physicians' perception of benefit and the results of clinical trials
22. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
23. Does it matter where you live? Treatment variation for breast cancer in Yorkshire
24. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews
25. Factors affecting treatment decisions for a life-threatening illness: The case of medial treatment of breast cancer
26. Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public
27. Surveillance versus adjuvant chemotherapy in stage I non-seminomatous testicular cancer: A decision analysis
28. Adjuvant chemotherapy in node negative breast cancer: Patterns of use and oncologists' preferences
29. Breast irradiation postlumpectomy: Development and evaluation of a decision instrument
30. Age and clinical decision making in oncology patients
31. Someone to live for: Social well-being, parenthood status, and decision-making in oncology